| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urea Cycle Disorders, Inborn | 25 | 2024 | 77 | 6.500 |
Why?
|
| Osteogenesis Imperfecta | 22 | 2025 | 148 | 4.760 |
Why?
|
| Phenylbutyrates | 12 | 2023 | 58 | 3.370 |
Why?
|
| Argininosuccinic Aciduria | 14 | 2024 | 47 | 2.850 |
Why?
|
| Hyperammonemia | 14 | 2024 | 62 | 2.140 |
Why?
|
| Argininosuccinate Lyase | 14 | 2021 | 57 | 2.050 |
Why?
|
| Chromosome Deletion | 8 | 2014 | 647 | 1.320 |
Why?
|
| Bone Density | 9 | 2024 | 318 | 1.200 |
Why?
|
| Glutamine | 9 | 2018 | 215 | 1.130 |
Why?
|
| Ammonia | 8 | 2024 | 74 | 1.030 |
Why?
|
| Genetic Testing | 6 | 2024 | 997 | 1.000 |
Why?
|
| Glycerol | 6 | 2019 | 92 | 0.980 |
Why?
|
| Osteoporosis | 2 | 2024 | 116 | 0.950 |
Why?
|
| Abnormalities, Multiple | 8 | 2018 | 956 | 0.910 |
Why?
|
| Phenylketonurias | 1 | 2023 | 13 | 0.860 |
Why?
|
| Developmental Disabilities | 7 | 2012 | 712 | 0.840 |
Why?
|
| Retinitis Pigmentosa | 1 | 2024 | 84 | 0.830 |
Why?
|
| Arginine | 10 | 2023 | 331 | 0.830 |
Why?
|
| Liver Transplantation | 7 | 2023 | 1036 | 0.820 |
Why?
|
| Fractures, Bone | 6 | 2024 | 186 | 0.790 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 141 | 0.790 |
Why?
|
| Liver Diseases | 4 | 2021 | 365 | 0.770 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2021 | 443 | 0.750 |
Why?
|
| Gene Rearrangement | 4 | 2015 | 319 | 0.740 |
Why?
|
| Child, Preschool | 32 | 2024 | 13998 | 0.730 |
Why?
|
| Child | 43 | 2024 | 24356 | 0.720 |
Why?
|
| Bone Diseases, Developmental | 2 | 2018 | 58 | 0.690 |
Why?
|
| Adult | 39 | 2025 | 29339 | 0.680 |
Why?
|
| Humans | 93 | 2025 | 124143 | 0.680 |
Why?
|
| Citrulline | 4 | 2023 | 107 | 0.670 |
Why?
|
| Male | 60 | 2024 | 60992 | 0.670 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2015 | 369 | 0.670 |
Why?
|
| Young Adult | 20 | 2024 | 8990 | 0.640 |
Why?
|
| Nitric Oxide | 6 | 2023 | 440 | 0.620 |
Why?
|
| Adolescent | 30 | 2024 | 19243 | 0.620 |
Why?
|
| Ethmoid Bone | 1 | 2018 | 8 | 0.610 |
Why?
|
| Sphenoid Bone | 1 | 2018 | 10 | 0.600 |
Why?
|
| Female | 60 | 2025 | 66274 | 0.600 |
Why?
|
| Quality of Life | 6 | 2024 | 1899 | 0.590 |
Why?
|
| Phenotype | 13 | 2022 | 4249 | 0.590 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 167 | 0.580 |
Why?
|
| Body Weight | 2 | 2020 | 996 | 0.570 |
Why?
|
| Benzoates | 1 | 2017 | 20 | 0.570 |
Why?
|
| Neurofibromatosis 1 | 1 | 2018 | 60 | 0.560 |
Why?
|
| Comparative Genomic Hybridization | 12 | 2015 | 571 | 0.550 |
Why?
|
| Body Height | 1 | 2018 | 215 | 0.550 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2014 | 77 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2011 | 150 | 0.510 |
Why?
|
| Collagen Type I | 5 | 2021 | 112 | 0.510 |
Why?
|
| Teriparatide | 4 | 2023 | 7 | 0.490 |
Why?
|
| Base Sequence | 6 | 2015 | 3089 | 0.490 |
Why?
|
| Chromosome Aberrations | 3 | 2011 | 617 | 0.490 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 853 | 0.490 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2015 | 15 | 0.490 |
Why?
|
| Steroid Isomerases | 1 | 2015 | 8 | 0.490 |
Why?
|
| DNA Copy Number Variations | 7 | 2017 | 948 | 0.480 |
Why?
|
| Alopecia | 1 | 2015 | 38 | 0.470 |
Why?
|
| Argininosuccinate Synthase | 4 | 2019 | 21 | 0.470 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 830 | 0.450 |
Why?
|
| Dwarfism | 1 | 2015 | 98 | 0.450 |
Why?
|
| Infant | 22 | 2024 | 12466 | 0.440 |
Why?
|
| Sequence Deletion | 2 | 2015 | 525 | 0.430 |
Why?
|
| Middle Aged | 20 | 2024 | 26587 | 0.430 |
Why?
|
| Hearing Loss | 2 | 2019 | 134 | 0.430 |
Why?
|
| Citrullinemia | 4 | 2024 | 15 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2014 | 142 | 0.400 |
Why?
|
| Cataract | 1 | 2015 | 222 | 0.400 |
Why?
|
| Self Report | 1 | 2015 | 512 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2012 | 140 | 0.390 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2012 | 124 | 0.380 |
Why?
|
| Cross-Over Studies | 5 | 2021 | 310 | 0.380 |
Why?
|
| Osteoblasts | 2 | 2024 | 148 | 0.380 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 82 | 0.380 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2011 | 41 | 0.370 |
Why?
|
| Cognition Disorders | 2 | 2012 | 551 | 0.370 |
Why?
|
| Urea | 4 | 2023 | 226 | 0.360 |
Why?
|
| Lung | 1 | 2018 | 1475 | 0.360 |
Why?
|
| Gene Dosage | 1 | 2012 | 439 | 0.350 |
Why?
|
| Pediatrics | 1 | 2019 | 1157 | 0.340 |
Why?
|
| Microcephaly | 3 | 2012 | 330 | 0.340 |
Why?
|
| Genes, X-Linked | 2 | 2024 | 59 | 0.340 |
Why?
|
| Chromosome Duplication | 1 | 2010 | 147 | 0.340 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2009 | 14 | 0.330 |
Why?
|
| Biomarkers | 9 | 2021 | 3050 | 0.320 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 54 | 0.320 |
Why?
|
| Bone Density Conservation Agents | 2 | 2023 | 51 | 0.310 |
Why?
|
| Phenylacetates | 2 | 2013 | 23 | 0.310 |
Why?
|
| Infant, Newborn | 16 | 2024 | 8189 | 0.310 |
Why?
|
| Severity of Illness Index | 7 | 2024 | 2881 | 0.310 |
Why?
|
| Proteins | 2 | 2023 | 1035 | 0.310 |
Why?
|
| Metabolism, Inborn Errors | 2 | 2021 | 114 | 0.310 |
Why?
|
| Cohort Studies | 6 | 2021 | 4780 | 0.300 |
Why?
|
| Genetic Therapy | 1 | 2012 | 678 | 0.280 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2017 | 126 | 0.260 |
Why?
|
| Mice | 18 | 2024 | 17584 | 0.260 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 2 | 2024 | 34 | 0.260 |
Why?
|
| Enterocytes | 2 | 2018 | 75 | 0.250 |
Why?
|
| Diphosphonates | 3 | 2023 | 38 | 0.250 |
Why?
|
| North America | 4 | 2019 | 239 | 0.250 |
Why?
|
| Chromosome Breakage | 4 | 2016 | 167 | 0.250 |
Why?
|
| Bone and Bones | 3 | 2024 | 265 | 0.250 |
Why?
|
| Genome, Human | 3 | 2017 | 1260 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 3151 | 0.240 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1889 | 0.240 |
Why?
|
| Metabolomics | 2 | 2019 | 421 | 0.240 |
Why?
|
| Liver | 5 | 2021 | 1733 | 0.240 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 3683 | 0.230 |
Why?
|
| Segmental Duplications, Genomic | 4 | 2015 | 81 | 0.230 |
Why?
|
| Mutation | 9 | 2024 | 5818 | 0.230 |
Why?
|
| Animals | 22 | 2024 | 33999 | 0.220 |
Why?
|
| Argininosuccinic Acid | 3 | 2012 | 7 | 0.220 |
Why?
|
| Osteoporotic Fractures | 1 | 2024 | 24 | 0.220 |
Why?
|
| Seizures | 4 | 2024 | 874 | 0.220 |
Why?
|
| Hyperargininemia | 2 | 2015 | 13 | 0.220 |
Why?
|
| SOX9 Transcription Factor | 1 | 2024 | 79 | 0.220 |
Why?
|
| Delphi Technique | 1 | 2025 | 211 | 0.220 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 64 | 0.210 |
Why?
|
| Neonatal Screening | 5 | 2020 | 184 | 0.210 |
Why?
|
| Disease Models, Animal | 10 | 2023 | 4334 | 0.210 |
Why?
|
| Fibroblasts | 3 | 2024 | 875 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 778 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 276 | 0.200 |
Why?
|
| Eye Proteins | 1 | 2024 | 220 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 311 | 0.200 |
Why?
|
| Neoplasms | 5 | 2018 | 2765 | 0.200 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 140 | 0.200 |
Why?
|
| Exons | 2 | 2017 | 797 | 0.200 |
Why?
|
| Gene Duplication | 4 | 2015 | 361 | 0.200 |
Why?
|
| Orthomyxoviridae | 1 | 2022 | 50 | 0.190 |
Why?
|
| Biosensing Techniques | 1 | 2022 | 48 | 0.190 |
Why?
|
| Hypertension | 3 | 2018 | 1316 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 372 | 0.190 |
Why?
|
| Nitric Acid | 1 | 2021 | 5 | 0.180 |
Why?
|
| Dopaminergic Neurons | 1 | 2021 | 48 | 0.180 |
Why?
|
| Genotype | 4 | 2020 | 2556 | 0.180 |
Why?
|
| Endothelial Cells | 3 | 2023 | 520 | 0.180 |
Why?
|
| Chronic Pain | 1 | 2022 | 122 | 0.180 |
Why?
|
| Human Development | 1 | 2020 | 6 | 0.180 |
Why?
|
| Glycolysis | 1 | 2021 | 148 | 0.170 |
Why?
|
| Quality Improvement | 1 | 2016 | 640 | 0.170 |
Why?
|
| Liver Glycogen | 1 | 2020 | 23 | 0.170 |
Why?
|
| Genomics | 5 | 2024 | 1491 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2018 | 211 | 0.170 |
Why?
|
| Locus Coeruleus | 1 | 2019 | 21 | 0.170 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2019 | 53 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 4392 | 0.160 |
Why?
|
| Membrane Proteins | 4 | 2024 | 1527 | 0.160 |
Why?
|
| Electroencephalography | 1 | 2024 | 863 | 0.160 |
Why?
|
| Chromosome Mapping | 3 | 2011 | 1079 | 0.160 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 16 | 0.160 |
Why?
|
| Cognition | 2 | 2019 | 707 | 0.160 |
Why?
|
| Chromosome Disorders | 1 | 2011 | 311 | 0.160 |
Why?
|
| Mobility Limitation | 1 | 2019 | 22 | 0.160 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 1015 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2022 | 280 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 129 | 0.160 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 128 | 0.160 |
Why?
|
| Aged | 7 | 2024 | 19532 | 0.160 |
Why?
|
| Vital Capacity | 1 | 2018 | 76 | 0.150 |
Why?
|
| Spirometry | 1 | 2018 | 74 | 0.150 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 1318 | 0.150 |
Why?
|
| Respiratory Function Tests | 1 | 2018 | 198 | 0.150 |
Why?
|
| Arginase | 2 | 2015 | 31 | 0.150 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 171 | 0.150 |
Why?
|
| Encephalocele | 1 | 2018 | 52 | 0.140 |
Why?
|
| Transcription Factors | 3 | 2018 | 2584 | 0.140 |
Why?
|
| Frontal Lobe | 1 | 2018 | 116 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2024 | 846 | 0.140 |
Why?
|
| Orbit | 1 | 2018 | 102 | 0.140 |
Why?
|
| Nitrogen | 1 | 2017 | 146 | 0.140 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 131 | 0.140 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2017 | 47 | 0.140 |
Why?
|
| Nitrogen Isotopes | 1 | 2017 | 63 | 0.140 |
Why?
|
| Syndrome | 4 | 2018 | 1118 | 0.140 |
Why?
|
| Alanine Transaminase | 2 | 2020 | 155 | 0.140 |
Why?
|
| Deuterium | 1 | 2017 | 109 | 0.140 |
Why?
|
| Isotope Labeling | 1 | 2017 | 104 | 0.140 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 3872 | 0.140 |
Why?
|
| Double-Blind Method | 3 | 2014 | 1629 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 555 | 0.140 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 1682 | 0.130 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 723 | 0.130 |
Why?
|
| Cesarean Section | 2 | 2021 | 387 | 0.130 |
Why?
|
| Carbon Isotopes | 1 | 2017 | 276 | 0.130 |
Why?
|
| Colitis | 1 | 2018 | 153 | 0.130 |
Why?
|
| Motor Activity | 1 | 2019 | 509 | 0.130 |
Why?
|
| Pyrimidines | 2 | 2018 | 369 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2021 | 931 | 0.130 |
Why?
|
| Species Specificity | 1 | 2017 | 549 | 0.130 |
Why?
|
| Molecular Docking Simulation | 1 | 2016 | 110 | 0.130 |
Why?
|
| Swine | 2 | 2017 | 1177 | 0.130 |
Why?
|
| Aspartic Acid | 1 | 2015 | 73 | 0.120 |
Why?
|
| Exome | 2 | 2024 | 1035 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 248 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2022 | 658 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2018 | 333 | 0.120 |
Why?
|
| Alu Elements | 1 | 2015 | 65 | 0.120 |
Why?
|
| Brain | 4 | 2015 | 2977 | 0.120 |
Why?
|
| Gene Order | 2 | 2011 | 79 | 0.120 |
Why?
|
| Gametogenesis | 1 | 2014 | 24 | 0.120 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.110 |
Why?
|
| Parkinson Disease | 1 | 2021 | 685 | 0.110 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 16 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2024 | 16273 | 0.110 |
Why?
|
| Neurons | 1 | 2024 | 1954 | 0.110 |
Why?
|
| Language Development Disorders | 2 | 2012 | 174 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1229 | 0.110 |
Why?
|
| Codon, Initiator | 1 | 2013 | 8 | 0.110 |
Why?
|
| Face | 2 | 2018 | 179 | 0.110 |
Why?
|
| Germ Cells | 1 | 2014 | 194 | 0.100 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 59 | 0.100 |
Why?
|
| Rats | 2 | 2017 | 3674 | 0.100 |
Why?
|
| Hepatic Encephalopathy | 1 | 2013 | 75 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2016 | 384 | 0.100 |
Why?
|
| Mosaicism | 1 | 2014 | 239 | 0.100 |
Why?
|
| Free Radicals | 1 | 2012 | 31 | 0.100 |
Why?
|
| Liver Function Tests | 1 | 2012 | 100 | 0.100 |
Why?
|
| Aspartate Aminotransferases | 1 | 2012 | 81 | 0.100 |
Why?
|
| DNA Repair | 2 | 2016 | 584 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 1942 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 332 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2018 | 565 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2018 | 1002 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 641 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2018 | 1555 | 0.100 |
Why?
|
| Sodium Benzoate | 1 | 2012 | 4 | 0.100 |
Why?
|
| Fumarates | 1 | 2012 | 18 | 0.100 |
Why?
|
| Placebos | 1 | 2012 | 240 | 0.100 |
Why?
|
| Point Mutation | 1 | 2013 | 346 | 0.100 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 67 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 171 | 0.090 |
Why?
|
| Organ Size | 1 | 2012 | 426 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 341 | 0.090 |
Why?
|
| Fragile X Syndrome | 1 | 2012 | 150 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 597 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2014 | 243 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 268 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 2389 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3414 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1423 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2011 | 64 | 0.090 |
Why?
|
| Diet, Protein-Restricted | 1 | 2012 | 81 | 0.090 |
Why?
|
| Recurrence | 2 | 2014 | 1421 | 0.080 |
Why?
|
| Osteogenesis | 2 | 2024 | 154 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2011 | 157 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 29 | 0.080 |
Why?
|
| Collagen | 2 | 2021 | 316 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2012 | 791 | 0.080 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2009 | 92 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1162 | 0.080 |
Why?
|
| Penetrance | 1 | 2009 | 102 | 0.080 |
Why?
|
| Lipids | 1 | 2012 | 512 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2019 | 3720 | 0.070 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 113 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2009 | 160 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 243 | 0.070 |
Why?
|
| Lumbar Vertebrae | 2 | 2022 | 113 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 541 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 869 | 0.070 |
Why?
|
| Dihydroorotase | 2 | 2018 | 6 | 0.070 |
Why?
|
| Aspartate Carbamoyltransferase | 2 | 2018 | 6 | 0.070 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 2 | 2018 | 6 | 0.070 |
Why?
|
| Intellectual Disability | 2 | 2018 | 1055 | 0.070 |
Why?
|
| Glucose | 1 | 2012 | 879 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2020 | 619 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3330 | 0.070 |
Why?
|
| Functional Neuroimaging | 1 | 2016 | 30 | 0.070 |
Why?
|
| Pregnancy | 3 | 2021 | 7174 | 0.070 |
Why?
|
| Facies | 2 | 2018 | 153 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1652 | 0.060 |
Why?
|
| Pedigree | 3 | 2016 | 1609 | 0.060 |
Why?
|
| Autistic Disorder | 1 | 2009 | 343 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1585 | 0.060 |
Why?
|
| Bone Remodeling | 2 | 2017 | 55 | 0.060 |
Why?
|
| Canada | 1 | 2016 | 300 | 0.060 |
Why?
|
| Europe | 1 | 2016 | 352 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2017 | 604 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3549 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2018 | 697 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 494 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2018 | 426 | 0.060 |
Why?
|
| DNA | 1 | 2009 | 1595 | 0.050 |
Why?
|
| Claudins | 1 | 2023 | 29 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 143 | 0.050 |
Why?
|
| Fracture Fixation | 1 | 2023 | 25 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 89 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2019 | 798 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 658 | 0.050 |
Why?
|
| Cell Movement | 2 | 2018 | 832 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2018 | 1613 | 0.050 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2012 | 10 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2023 | 142 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12286 | 0.050 |
Why?
|
| DNA Replication | 2 | 2016 | 352 | 0.050 |
Why?
|
| Retinal Dehydrogenase | 1 | 2021 | 10 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2009 | 819 | 0.050 |
Why?
|
| Megalencephaly | 2 | 2012 | 57 | 0.050 |
Why?
|
| Biological Assay | 1 | 2022 | 102 | 0.050 |
Why?
|
| Growth Plate | 1 | 2021 | 20 | 0.050 |
Why?
|
| Ornithine | 2 | 2011 | 31 | 0.050 |
Why?
|
| Time Factors | 2 | 2016 | 6281 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 762 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 3266 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 1388 | 0.050 |
Why?
|
| Alleles | 2 | 2016 | 1615 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 2 | 2011 | 186 | 0.040 |
Why?
|
| Weights and Measures | 1 | 2020 | 6 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 38 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 373 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 99 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2021 | 174 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2023 | 476 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 4609 | 0.040 |
Why?
|
| Catecholamines | 1 | 2019 | 58 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2141 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1370 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 234 | 0.040 |
Why?
|
| Stem Cells | 1 | 2024 | 694 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 456 | 0.040 |
Why?
|
| COS Cells | 1 | 2019 | 275 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 918 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 29 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 1 | 2018 | 16 | 0.040 |
Why?
|
| Hypotrichosis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2283 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 94 | 0.040 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2018 | 10 | 0.040 |
Why?
|
| SMARCB1 Protein | 1 | 2018 | 38 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2018 | 17 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 605 | 0.040 |
Why?
|
| Micrognathism | 1 | 2018 | 65 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 61 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 314 | 0.040 |
Why?
|
| Cancellous Bone | 1 | 2017 | 7 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 430 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 118 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 1 | 2018 | 88 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 187 | 0.040 |
Why?
|
| Cell Line | 2 | 2014 | 2734 | 0.040 |
Why?
|
| Epigenomics | 1 | 2018 | 163 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 438 | 0.040 |
Why?
|
| Neck | 1 | 2018 | 137 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 949 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 329 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2019 | 355 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2863 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2018 | 231 | 0.030 |
Why?
|
| RecQ Helicases | 1 | 2017 | 62 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 239 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 675 | 0.030 |
Why?
|
| Sirolimus | 1 | 2018 | 223 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 518 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2016 | 63 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 1748 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 6121 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 113 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2018 | 252 | 0.030 |
Why?
|
| Organic Anion Transporters | 1 | 2015 | 16 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 567 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 280 | 0.030 |
Why?
|
| Chromosomes | 1 | 2016 | 199 | 0.030 |
Why?
|
| Mitosis | 1 | 2016 | 235 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1179 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 87 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 258 | 0.030 |
Why?
|
| Cytosol | 1 | 2015 | 161 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1173 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 520 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1559 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2015 | 91 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2016 | 448 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 543 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 548 | 0.030 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2014 | 10 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 416 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 324 | 0.030 |
Why?
|
| Fasting | 1 | 2015 | 299 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2014 | 139 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2014 | 27 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 64 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 674 | 0.030 |
Why?
|
| Birth Weight | 1 | 2015 | 346 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2015 | 228 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2018 | 908 | 0.030 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2014 | 105 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 177 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2815 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 532 | 0.030 |
Why?
|
| Infant Formula | 1 | 2014 | 97 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 646 | 0.030 |
Why?
|
| Osteopetrosis | 1 | 2013 | 14 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 512 | 0.030 |
Why?
|
| Kidney | 1 | 2020 | 1353 | 0.030 |
Why?
|
| Cell Division | 1 | 2014 | 776 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 241 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 1350 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3028 | 0.030 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2013 | 46 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2014 | 314 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1266 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 217 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 754 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 419 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 1059 | 0.020 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 500 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1699 | 0.020 |
Why?
|
| Orotic Acid | 1 | 2011 | 3 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 46 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 875 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2012 | 225 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2014 | 759 | 0.020 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2012 | 220 | 0.020 |
Why?
|
| Carboxy-Lyases | 1 | 2011 | 15 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 31 | 0.020 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2011 | 17 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 823 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 257 | 0.020 |
Why?
|
| United States | 1 | 2016 | 10855 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1799 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1007 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 354 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 2047 | 0.020 |
Why?
|
| Family | 1 | 2013 | 563 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5132 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 623 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2012 | 542 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 1103 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1709 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1778 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2089 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 10244 | 0.010 |
Why?
|